Click on the protein name for more information about the protein.
The Score column is the predicted score of interaction between the two proteins
Click on the Evidence link to view a breakdown of the information about the predicted interaction.
| Key | |
|---|---|
| Module Score | Databases |
 | Where interaction is observed in another database a link is provided: |
| Protein 1 (?) | Protein 2 (?) | Name of Protein 2 | Module Scores (?) | Scores (?) | Evidence (?) | Database (?) | |||
|---|---|---|---|---|---|---|---|---|---|
 |  |  |  | ||||||
| SRC | JAK2 | JAK2: Tyrosine-protein kinase JAK2 | 345.0 | Evidence | |||||
| SRC | FYN | FYN: Proto-oncogene tyrosine-protein kinase Fyn | 299.0 | Evidence | |||||
| SRC | STAT5A | STAT5A, STAT5: Signal transducer and activator of transcription 5A | 275.0 | Evidence |
|
||||
| SRC | CRKL | CRKL: Crk-like protein | 275.0 | Evidence | |||||
| SRC | NCK2 | NCK2: Cytoplasmic protein NCK2 | 223.0 | Evidence | |||||
| SRC | BLNK | BLNK, BASH, SLP65: B-cell linker protein | 221.0 | Evidence | |||||
| SRC | TEC | TEC, PSCTK4: Tyrosine-protein kinase Tec | 209.0 | Evidence | |||||
| SRC | EPHB1 | EPHT2, EPHB1, NET: Ephrin type-B receptor 1 precursor | 206.0 | Evidence | |||||
| SRC | STAT5B | STAT5B: Signal transducer and activator of transcription 5B | 206.0 | Evidence |
|
||||
| SRC | EPHB4 | EPHB4, HTK, TYRO11: Ephrin type-B receptor 4 precursor | 206.0 | Evidence | |||||
| SRC | GRB2 | GRB2, ASH: Growth factor receptor-bound protein 2 | 181.0 | Evidence |
|
||||
| SRC | BTK | BTK, AGMX1, ATK, BPK: Tyrosine-protein kinase BTK | 181.0 | Evidence | |||||
| SRC | CSK | CSK: Tyrosine-protein kinase CSK | 181.0 | Evidence |
|
||||
| SRC | SYK | SYK: Tyrosine-protein kinase SYK | 181.0 | Evidence |
|
||||
| SRC | LYN | LYN: Tyrosine-protein kinase Lyn | 181.0 | Evidence | |||||
| SRC | FGR | FGR, SRC2: Proto-oncogene tyrosine-protein kinase FGR | 180.0 | Evidence |
|
||||
| SRC | HCK | N/A | 180.0 | Evidence | |||||
| SRC | EPHB2 | EPHB2, DRT, EPHT3, EPTH3, ERK, HEK5, TYRO5: Ephrin type-B receptor 2 precursor | 167.0 | Evidence |
|
||||
| SRC | KIT | KIT: Mast/stem cell growth factor receptor precursor | 167.0 | Evidence |
|
||||
| SRC | PDGFRB | PDGFRB: Beta-type platelet-derived growth factor receptor precursor | 167.0 | Evidence |
|
||||
| SRC | NCK1 | NCK1, NCK: Cytoplasmic protein NCK1 | 167.0 | Evidence | |||||
| SRC | CBL | CBL, CBL2, RNF55: E3 ubiquitin-protein ligase CBL | 156.0 | Evidence |
|
||||
| SRC | STAT3 | 156.0 | Evidence |
|
|||||
| SRC | PDGFRA | PDGFRA: Alpha-type platelet-derived growth factor receptor precursor | 147.0 | Evidence | |||||
| SRC | VAV1 | VAV1, VAV: Proto-oncogene vav | 137.0 | Evidence | |||||
| SRC | ABL1 | ABL1, ABL, JTK7: Proto-oncogene tyrosine-protein kinase ABL1 | 137.0 | Evidence |
|
||||
| SRC | APS | SH2B2, APS: SH2B adapter protein 2 | 137.0 | Evidence | |||||
| SRC | SH3BP2 | SH3BP2: Uncharacterized protein SH3BP2 | 137.0 | Evidence | |||||
| SRC | STAT1 | STAT1: Signal transducer and activator of transcription 1-alpha/beta | 135.0 | Evidence |
|
||||
| SRC | PIK3R2 | PIK3R2: Phosphatidylinositol 3-kinase regulatory subunit beta | 135.0 | Evidence | |||||
| SRC | ZAP70 | ZAP70: Uncharacterized protein ZAP70 | 119.0 | Evidence | |||||
| SRC | PTK2B | PTK2B, FAK2, PYK2, RAFTK: Protein tyrosine kinase 2 beta | 119.0 | Evidence |
|
||||
| SRC | PTPN6 | PTPN6, HCP, PTP1C: Tyrosine-protein phosphatase non-receptor type 6 | 119.0 | Evidence |
|
||||
| SRC | RASA1 | RASA1, RASA: Ras GTPase-activating protein 1 | 119.0 | Evidence |
|
||||
| SRC | ERBB3 | ERBB3, HER3: Receptor tyrosine-protein kinase erbB-3 precursor | 117.0 | Evidence | |||||
| SRC | EGFR | EGFR, ERBB1: Epidermal growth factor receptor precursor | 117.0 | Evidence |
|
||||
| SRC | YES1 | YES1, YES: Proto-oncogene tyrosine-protein kinase Yes | 109.0 | Evidence | |||||
| SRC | INSL3 | JAK3: Tyrosine-protein kinase JAK3 | 109.0 | Evidence | |||||
| SRC | INSR | INSR: Insulin receptor precursor | 101.0 | Evidence |
|
||||
| SRC | KDR | KDR, FLK1: Vascular endothelial growth factor receptor 2 precursor | 89.30 | Evidence |
|
||||
| SRC | JAK1 | 88.80 | Evidence | ||||||
| SRC | FLT1 | FLT1, FLT, FRT: Vascular endothelial growth factor receptor 1 precursor | 87.30 | Evidence | |||||
| SRC | CBLB | CBLB, RNF56, Nbla00127: E3 ubiquitin-protein ligase CBL-B | 82.10 | Evidence | |||||
| SRC | LCK | LCK: Proto-oncogene tyrosine-protein kinase LCK | 78.20 | Evidence | |||||
| SRC | ERBB2 | ERBB2, HER2, NEU, NGL: Receptor tyrosine-protein kinase erbB-2 precursor | 76.90 | Evidence |
|
||||
| SRC | EPHA4 | EPHA4, HEK8, SEK, TYRO1: Ephrin type-A receptor 4 precursor | 76.90 | Evidence | |||||
| SRC | LCP2 | LCP2: Lymphocyte cytosolic protein 2 | 66.50 | Evidence | |||||
| SRC | IGF1R | IGF1R: Insulin-like growth factor 1 receptor precursor | 66.50 | Evidence |
|
||||
| SRC | GRB10 | N/A | 56.20 | Evidence |
|
||||
| SRC | GRAP | GRAP: GRB2-related adapter protein | 29.10 | Evidence | |||||
| SRC | DOK1 | DOK1: Docking protein 1 | 27.90 | Evidence |
|
||||
| SRC | MAP2K2 | MAP2K2, MEK2, MKK2, PRKMK2: Dual specificity mitogen-activated protein kinase ki | 26.40 | Evidence | |||||
| SRC | RAF1 | RAF1, RAF: RAF proto-oncogene serine/threonine-protein kinase | 26.40 | Evidence |
|
||||
| SRC | SHC3 | SHC3, NSHC, SHCC: SHC-transforming protein 3 | 23.50 | Evidence | |||||
| SRC | WAS | WAS, IMD2: Wiskott-Aldrich syndrome protein | 22.70 | Evidence |
|
||||
| SRC | FRS3 | FRS3: Fibroblast growth factor receptor substrate 3 | 22.70 | Evidence | |||||
| SRC | HCLS1 | HCLS1, HS1: Hematopoietic lineage cell-specific protein | 22.70 | Evidence | |||||
| SRC | WASPIP | N/A | 21.10 | Evidence | |||||
| SRC | PDPK1 | PDPK1, PDK1: 3-phosphoinositide-dependent protein kinase 1 | 19.70 | Evidence |
|
||||
| SRC | CDC25A | CDC25A: M-phase inducer phosphatase 1 | 19.70 | Evidence | |||||
| SRC | MAP2K1 | MAP2K1, MEK1, PRKMK1: Dual specificity mitogen-activated protein kinase kinase 1 | 17.30 | Evidence | |||||
| SRC | MAPK3 | MAPK3, ERK1, PRKM3: Mitogen-activated protein kinase 3 | 17.10 | Evidence | |||||
| SRC | PTPN2 | PTPN2, PTPT: Tyrosine-protein phosphatase non-receptor type 2 | 15.10 | Evidence |
|
||||
| SRC | PRKCE | PRKCE, PKCE: Protein kinase C epsilon type | 13.80 | Evidence |
|
||||
| SRC | WASL | WASL: Neural Wiskott-Aldrich syndrome protein | 13.80 | Evidence | |||||
| SRC | GSK3A | GSK3A: Glycogen synthase kinase-3 alpha | 13.80 | Evidence | |||||
| SRC | PTPN12 | PTPN12: Tyrosine-protein phosphatase non-receptor type 12 | 11.20 | Evidence | |||||
| SRC | EFNB2 | EFNB2, EPLG5, HTKL, LERK5: Ephrin-B2 precursor | 10.30 | Evidence |
|
||||
| SRC | PRKCA | PRKCA, PKCA, PRKACA: Protein kinase C alpha type | 9.89 | Evidence |
|
||||
| SRC | PRKCG | PRKCG, PKCG: Protein kinase C gamma type | 9.89 | Evidence | |||||
| SRC | CTTN | CTTN, EMS1: Src substrate cortactin | 9.89 | Evidence |
|
||||
| SRC | SOS1 | SOS1: Son of sevenless homolog 1 | 9.14 | Evidence | |||||
| SRC | PARD6A | PARD6A, PAR6A: Partitioning defective 6 homolog alpha | 7.59 | Evidence | |||||
| SRC | IL2RB | IL2RB: Interleukin-2 receptor subunit beta precursor | 7.40 | Evidence | |||||
| SRC | EPOR | EPOR: Erythropoietin receptor precursor | 6.52 | Evidence | |||||
| SRC | EFNB1 | EFNB1, EFL-3, EPLG2, LERK2: Ephrin-B1 precursor | 6.13 | Evidence |
|
||||
| SRC | NRAS | NRAS, HRAS1: GTPase NRas precursor | 5.08 | Evidence | |||||
| SRC | IKBKE | IKBKE, IKKE, IKKI, KIAA0151: Inhibitor of nuclear factor kappa-B kinase subunit | 4.68 | Evidence | |||||
| SRC | SLC9A3 | SLC9A3, NHE3: Sodium/hydrogen exchanger 3 | 4.12 | Evidence | |||||
| SRC | YWHAB | YWHAB: 14-3-3 protein beta/alpha | 3.57 | Evidence |
|
||||
| SRC | CAV1 | CAV1, CAV: Caveolin-1 | 3.49 | Evidence |
|
||||
| SRC | GIT2 | N/A | 3.34 | Evidence | |||||
| SRC | PPID | PPID, CYP40, CYPD: 40 kDa peptidyl-prolyl cis-trans isomerase | 2.94 | Evidence | |||||
| SRC | FIGF | FIGF, VEGFD: Vascular endothelial growth factor D precursor | 2.65 | Evidence | |||||
| SRC | GRIN2A | GRIN2A, NMDAR2A: Glutamate [NMDA] receptor subunit epsilon-1 precursor | 2.29 | Evidence |
|
||||
| SRC | RELA | RELA, NFKB3: Transcription factor p65 | 1.98 | Evidence | |||||
| SRC | TYK2 | TYK2: Non-receptor tyrosine-protein kinase TYK2 | 1.72 | Evidence | |||||
| SRC | SOCS3 | SOCS3, CIS3, SSI3: Suppressor of cytokine signaling 3 | 1.72 | Evidence | |||||
| SRC | STAT6 | STAT6: Signal transducer and activator of transcription 6 | 1.72 | Evidence |
|
||||
| SRC | APC | N/A | 1.67 | Evidence | |||||
| SRC | B2M | B2M, CDABP0092, HDCMA22P: Beta-2-microglobulin precursor [Contains: Beta-2-micro | 1.62 | Evidence | |||||
| SRC | CREBBP | CREBBP, CBP: CREB-binding protein | 1.57 | Evidence | |||||
| SRC | GNA12 | GNA12: Guanine nucleotide-binding protein alpha-12 subunit | 1.20 | Evidence | |||||
| SRC | EPHB6 | EPHB6: Ephrin type-B receptor 6 precursor | 1.13 | Evidence | |||||
| SRC | SLA2 | SLA2, C20orf156, SLAP2: Src-like-adapter 2 | 1.13 | Evidence | |||||
| SRC | MATK | MATK, CTK, HYL: Megakaryocyte-associated tyrosine-protein kinase | 1.13 | Evidence | |||||
| SRC | ITK | ITK, EMT, LYK: Tyrosine-protein kinase ITK/TSK | 1.13 | Evidence | |||||
| SRC | LNK | SH2B3, LNK: SH2B adapter protein 3 | 1.13 | Evidence | |||||
| SRC | ABL2 | ABL2, ABLL, ARG: Tyrosine-protein kinase ABL2 | 1.13 | Evidence | |||||
| SRC | RIN1 | RIN1: Ras and Rab interactor 1 | 1.04 | Evidence | |||||
| SRC | PTK6 | PTK6, BRK: Tyrosine-protein kinase 6 | 1.04 | Evidence | |||||
| SRC | FER | FER, TYK3: Proto-oncogene tyrosine-protein kinase FER | 1.04 | Evidence | |||||
| SRC | BMX | N/A | 1.04 | Evidence |
|
||||
| SRC | TESK1 | TESK1: Dual specificity testis-specific protein kinase 1 | 1.04 | Evidence | |||||
| SRC | EFNA5 | EFNA5, EPLG7, LERK7: Ephrin-A5 precursor | 0.995 | Evidence | |||||
| SRC | STAT2 | STAT2: Signal transducer and activator of transcription 2 | 0.978 | Evidence | |||||
| SRC | FLT3 | FLT3, STK1: FL cytokine receptor precursor | 0.978 | Evidence | |||||
| SRC | PARD6G | PARD6G, PAR6G: Partitioning defective 6 homolog gamma | 0.978 | Evidence | |||||
| SRC | RET | RET: Proto-oncogene tyrosine-protein kinase receptor ret precursor | 0.848 | Evidence |
|
||||
| SRC | FGFR1 | FGFR1, FGFBR, FLG, FLT2: Basic fibroblast growth factor receptor 1 precursor | 0.848 | Evidence | |||||
| SRC | FGFR3 | FGFR3, JTK4: Fibroblast growth factor receptor 3 precursor | 0.848 | Evidence | |||||
| SRC | AXL | AXL, UFO: Tyrosine-protein kinase receptor UFO precursor | 0.848 | Evidence |
|
||||
| SRC | EPHA8 | EPHA8, EEK, KIAA1459: Ephrin type-A receptor 8 precursor | 0.848 | Evidence | |||||
| SRC | FRK | FRK, PTK5, RAK: Tyrosine-protein kinase FRK | 0.845 | Evidence | |||||
| SRC | SLA | SLA, SLAP, SLAP1: SRC-like-adapter | 0.845 | Evidence | |||||
| SRC | CSF1R | CSF1R, FMS: Macrophage colony-stimulating factor 1 receptor precursor | 0.78 | Evidence | |||||
| SRC | EPHA2 | EPHA2, ECK: Ephrin type-A receptor 2 precursor | 0.78 | Evidence | |||||
| SRC | CBLC | CBLC, CBL3, RNF57: Signal transduction protein CBL-C | 0.78 | Evidence |
|
||||
| SRC | FGFR4 | FGFR4, JTK2, TKF: Fibroblast growth factor receptor 4 precursor | 0.78 | Evidence | |||||
| SRC | MERTK | MERTK, MER: Proto-oncogene tyrosine-protein kinase MER precursor | 0.78 | Evidence | |||||
| SRC | SH2D2A | SH2D2A, SCAP, TSAD, VRAP: SH2 domain-containing protein 2A | 0.742 | Evidence | |||||
| SRC | GRAP2 | GRAP2, GADS, GRB2L, GRID: GRB2-related adapter protein 2 | 0.742 | Evidence | |||||
| SRC | PLCG1 | PLCG1, PLC1: 1-phosphatidylinositol-4,5-bisphosphate phosphodiesterase gamma-1 | 0.742 | Evidence | |||||
| SRC | TXK | TXK, PTK4: Tyrosine-protein kinase TXK | 0.742 | Evidence |
|
||||
| SRC | PTK2 | PTK2, FAK, FAK1: Focal adhesion kinase 1 | 0.742 | Evidence |
|
||||
| SRC | SEC23A | SEC23A: Protein transport protein Sec23A | 0.69 | Evidence | |||||
| SRC | MST1R | MST1R, PTK8, RON: Macrophage-stimulating protein receptor precursor | 0.632 | Evidence |
|
||||
| SRC | TEK | TEK, TIE2: Angiopoietin-1 receptor precursor | 0.632 | Evidence | |||||
| SRC | MET | MET: Hepatocyte growth factor receptor precursor | 0.632 | Evidence |
|
||||
| SRC | EPHB3 | EPHB3, ETK2, HEK2, TYRO6: Ephrin type-B receptor 3 precursor | 0.632 | Evidence | |||||
| SRC | EPHA1 | EPHA1, EPH, EPHT, EPHT1: Ephrin type-A receptor 1 precursor | 0.558 | Evidence | |||||
| SRC | STAT4 | STAT4: Signal transducer and activator of transcription 4 | 0.558 | Evidence | |||||
| SRC | EPHA7 | EPHA7, EHK3, HEK11: Ephrin type-A receptor 7 precursor | 0.558 | Evidence | |||||
| SRC | SHC1 | SHC1, SHC, SHCA: SHC-transforming protein 1 | 0.535 | Evidence | |||||
| SRC | NTRK2 | NTRK2, TRKB: BDNF/NT-3 growth factors receptor precursor | 0.535 | Evidence | |||||
| SRC | TNK2 | TNK2, ACK1: Activated CDC42 kinase 1 | 0.535 | Evidence | |||||
| SRC | NTRK1 | NTRK1, TRK: High affinity nerve growth factor receptor precursor | 0.535 | Evidence | |||||
| SRC | PTK7 | PTK7, CCK4: Tyrosine-protein kinase-like 7 precursor | 0.535 | Evidence | |||||
| SRC | EPHA3 | EPHA3, ETK, ETK1, HEK, TYRO4: Ephrin type-A receptor 3 precursor | 0.535 | Evidence | |||||
| SRC | CRK | CRK: Proto-oncogene C-crk | 0.535 | Evidence | |||||
| SRC | VAV2 | VAV2: Uncharacterized protein VAV2 | 0.535 | Evidence | |||||
| SRC | PLCG2 | PLCG2: 1-phosphatidylinositol-4,5-bisphosphate phosphodiesterase gamma-2 | 0.535 | Evidence | |||||
| SRC | PTPN11 | PTPN11, PTP2C, SHPTP2: Tyrosine-protein phosphatase non-receptor type 11 | 0.535 | Evidence | |||||
| SRC | FLT4 | VEGFR3 long form | 0.535 | Evidence | |||||
| SRC | ERBB4 | ERBB4, HER4: Receptor tyrosine-protein kinase erbB-4 precursor | 0.502 | Evidence | |||||
-